Objective To study the human myxovirus resistant protein A （MxA）, a specifically induced peptide by interferon I, and to use its level as a diagnostic criterion for viral infections. Methods Anti-MxA antisera from i...Objective To study the human myxovirus resistant protein A （MxA）, a specifically induced peptide by interferon I, and to use its level as a diagnostic criterion for viral infections. Methods Anti-MxA antisera from immunized mice were prepared with the expressed MxA protein of pET32a-MxA in E. coli BL-21（DE3）. To confirm the antiserum activity and specificity, the expression product of BL21, wild type MxA pEGFP-CI-wMxA and site-directed mutant MxA pEGFP-Cl-mMxA（N589S） stably transfected 3T3 cells and induced A549 cells were detected by Western blot with the antisera using non-MxA transfected or non-IFN-[3 induced cells, intact A549, NIH 3T3 cells transfected with pEGFP-CI and pET32a （＋）-transformed BL-21 as controls. Results The antisera had specific positive immunoreactivity to the NIH3T3 cells transformed with pEGFP-CI-wMxA and pEGFP-CI-mMxA, INF-β induced A549 cells and BL21 proteins expressed with pET32a （＋）-MxA. The hybridization signals from IFN-β induced A549 cells depended on the IFN-β inducing concentrations. Meanwhile, immunohistochemical assay showed that NIH 3T3 cells with pEGFP-C 1-wMxA and pEGFP-C 1-mMxA had 〉 98% of positive cells at 1：50 dilution of the serum and A549 cells induced by 20 ng/mL IFN-[3 for 48 h showed 95% positive cells. pEGFP-Cl-transfected NIH 3T3 cells were all negative. Conclusion Anti-sera are highly specific to diversified MxAs. The antibody is detectable by Western blot, immunocytochemistry and immunofluorescence assay.展开更多
Objective:To explore the expression of human myxovirus resistance protein A(MxA)in triple negative breast cancer(TNBC)and its relationship with prognosis.Methods:144 cases of TNBC confirmed by pathology before or afte...Objective:To explore the expression of human myxovirus resistance protein A(MxA)in triple negative breast cancer(TNBC)and its relationship with prognosis.Methods:144 cases of TNBC confirmed by pathology before or after surgery from January 2014 to January 2017 in the First Central Hospital of Baoding City were retrospectively collected.Western blotting was used to detect the expression of MxA protein in TNBC and adjacent breast tissues.According to the expression of MxA protein,144 TNBC patients were divided into low MxA protein expression group(n=91)and MxA protein high expression group(n=53)for subsequent comparison of prognosis of patients in between these two groups.Results:The expression of MxA protein in TNBC tissue was lower than that of adjacent breast tissue,and the difference was statistically significant(P<0.05).The patients in high MxA expression group had higher loco-regional recurrence-free rate,disease-free survival(DFS)rate,and overall survival(OS)rate than those in low MxA expression group for 3 years.On the other hand,the distant metastasis rate was lower in the high expression group compared to that in the low MxA expression group,and the difference was statistically significant(P<0.05).Conclusion:In triple-negative breast cancer,high MxA expression is a potential predictor of TNBC prognosis.展开更多
黏病毒抗性蛋白A(myxovirus resistance protein A,MxA)是由干扰素诱导的具有重要抗乙肝病毒(hepatitis B virus,HBV)功能的蛋白质,我们前期工作发现,MxA主要依赖其中心互作结构域(central interactive domain,CID)与病毒直接相互作用...黏病毒抗性蛋白A(myxovirus resistance protein A,MxA)是由干扰素诱导的具有重要抗乙肝病毒(hepatitis B virus,HBV)功能的蛋白质,我们前期工作发现,MxA主要依赖其中心互作结构域(central interactive domain,CID)与病毒直接相互作用发挥功能,但其具体的抗病毒功能区以及功能区是否具有独立的抗病毒活性仍不清楚。本研究拟鉴定MxA蛋白上的抗乙肝病毒活性肽。首先从全长MxA构建缺失突变体ΔCID和截短体CID,以HepG2.2.15细胞为病毒模型,分别转染空载质粒、MxA、ΔCID和CID,免疫荧光法检测转染效率,Western印迹法检测质粒表达,酶联免疫法测定细胞培养液中HBsAg、HBeAg的量及荧光定量PCR法测定乙肝病毒DNA的量,评估CID段的抗乙肝病毒活性。根据CID段的晶体结构,缩短肽段长度,构建α1、α2、α3等9段肽段质粒,鉴定各段的抗乙肝病毒活性和细胞毒性(MTT法)。运用计算生物学手段——分子对接法预测MxA蛋白与病毒相互作用的模式和位点。结果显示,ΔCID、CID和9段肽段质粒的序列及表达正确,9段肽段的表达量未见显著性差异,无显著的细胞毒性。CID组和黏病毒抗性蛋白A组较对照组乙肝病毒的复制水平显著降低,CID组细胞上清中HBsAg、HBeAg及乙肝病毒DNA的量分别减少了55.57%±8.48%、68.37%±6.24%、66.67%±6.40%,P<0.01;MxA组的3个指标分别减少了61.63%±3.11%、70.77%±7.25%、73.73%±6.18%,P<0.01;ΔCID组较对照组无明显变化。9段肽段中α1组较对照组HBsAg、HBeAg及乙肝病毒DNA的量有显著下降,分别减少了48.33%±1.70%、70.67%±3.30%、68.95%±2.55%,P<0.001,表明α1对乙肝病毒具有强抑制活性。分子对接的结果显示,384~408位氨基酸是MxA蛋白与病毒互作的关键位点,该区域落在α1肽段上,验证了α1是MxA蛋白抗乙肝病毒及与乙肝病毒相互作用中的关键区段。本研究筛选并鉴定出人干扰素诱导蛋白MxA上最有效的抗乙肝病毒活性肽α1,研究结果为抗乙肝病毒多肽类新药的研发奠定了基础。展开更多
基金supported by Educational Committee of Jiangsu Province (Grant No: 07KJD180183)
文摘Objective To study the human myxovirus resistant protein A （MxA）, a specifically induced peptide by interferon I, and to use its level as a diagnostic criterion for viral infections. Methods Anti-MxA antisera from immunized mice were prepared with the expressed MxA protein of pET32a-MxA in E. coli BL-21（DE3）. To confirm the antiserum activity and specificity, the expression product of BL21, wild type MxA pEGFP-CI-wMxA and site-directed mutant MxA pEGFP-Cl-mMxA（N589S） stably transfected 3T3 cells and induced A549 cells were detected by Western blot with the antisera using non-MxA transfected or non-IFN-[3 induced cells, intact A549, NIH 3T3 cells transfected with pEGFP-CI and pET32a （＋）-transformed BL-21 as controls. Results The antisera had specific positive immunoreactivity to the NIH3T3 cells transformed with pEGFP-CI-wMxA and pEGFP-CI-mMxA, INF-β induced A549 cells and BL21 proteins expressed with pET32a （＋）-MxA. The hybridization signals from IFN-β induced A549 cells depended on the IFN-β inducing concentrations. Meanwhile, immunohistochemical assay showed that NIH 3T3 cells with pEGFP-C 1-wMxA and pEGFP-C 1-mMxA had 〉 98% of positive cells at 1：50 dilution of the serum and A549 cells induced by 20 ng/mL IFN-[3 for 48 h showed 95% positive cells. pEGFP-Cl-transfected NIH 3T3 cells were all negative. Conclusion Anti-sera are highly specific to diversified MxAs. The antibody is detectable by Western blot, immunocytochemistry and immunofluorescence assay.
基金The Health and Biomedical Special Project of Hebei Province Key R&D Project(2018)(18277732D)。
文摘Objective:To explore the expression of human myxovirus resistance protein A(MxA)in triple negative breast cancer(TNBC)and its relationship with prognosis.Methods:144 cases of TNBC confirmed by pathology before or after surgery from January 2014 to January 2017 in the First Central Hospital of Baoding City were retrospectively collected.Western blotting was used to detect the expression of MxA protein in TNBC and adjacent breast tissues.According to the expression of MxA protein,144 TNBC patients were divided into low MxA protein expression group(n=91)and MxA protein high expression group(n=53)for subsequent comparison of prognosis of patients in between these two groups.Results:The expression of MxA protein in TNBC tissue was lower than that of adjacent breast tissue,and the difference was statistically significant(P<0.05).The patients in high MxA expression group had higher loco-regional recurrence-free rate,disease-free survival(DFS)rate,and overall survival(OS)rate than those in low MxA expression group for 3 years.On the other hand,the distant metastasis rate was lower in the high expression group compared to that in the low MxA expression group,and the difference was statistically significant(P<0.05).Conclusion:In triple-negative breast cancer,high MxA expression is a potential predictor of TNBC prognosis.
文摘黏病毒抗性蛋白A(myxovirus resistance protein A,MxA)是由干扰素诱导的具有重要抗乙肝病毒(hepatitis B virus,HBV)功能的蛋白质,我们前期工作发现,MxA主要依赖其中心互作结构域(central interactive domain,CID)与病毒直接相互作用发挥功能,但其具体的抗病毒功能区以及功能区是否具有独立的抗病毒活性仍不清楚。本研究拟鉴定MxA蛋白上的抗乙肝病毒活性肽。首先从全长MxA构建缺失突变体ΔCID和截短体CID,以HepG2.2.15细胞为病毒模型,分别转染空载质粒、MxA、ΔCID和CID,免疫荧光法检测转染效率,Western印迹法检测质粒表达,酶联免疫法测定细胞培养液中HBsAg、HBeAg的量及荧光定量PCR法测定乙肝病毒DNA的量,评估CID段的抗乙肝病毒活性。根据CID段的晶体结构,缩短肽段长度,构建α1、α2、α3等9段肽段质粒,鉴定各段的抗乙肝病毒活性和细胞毒性(MTT法)。运用计算生物学手段——分子对接法预测MxA蛋白与病毒相互作用的模式和位点。结果显示,ΔCID、CID和9段肽段质粒的序列及表达正确,9段肽段的表达量未见显著性差异,无显著的细胞毒性。CID组和黏病毒抗性蛋白A组较对照组乙肝病毒的复制水平显著降低,CID组细胞上清中HBsAg、HBeAg及乙肝病毒DNA的量分别减少了55.57%±8.48%、68.37%±6.24%、66.67%±6.40%,P<0.01;MxA组的3个指标分别减少了61.63%±3.11%、70.77%±7.25%、73.73%±6.18%,P<0.01;ΔCID组较对照组无明显变化。9段肽段中α1组较对照组HBsAg、HBeAg及乙肝病毒DNA的量有显著下降,分别减少了48.33%±1.70%、70.67%±3.30%、68.95%±2.55%,P<0.001,表明α1对乙肝病毒具有强抑制活性。分子对接的结果显示,384~408位氨基酸是MxA蛋白与病毒互作的关键位点,该区域落在α1肽段上,验证了α1是MxA蛋白抗乙肝病毒及与乙肝病毒相互作用中的关键区段。本研究筛选并鉴定出人干扰素诱导蛋白MxA上最有效的抗乙肝病毒活性肽α1,研究结果为抗乙肝病毒多肽类新药的研发奠定了基础。
